Price T Rowe Associates Inc. MD lifted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 41.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 554,688 shares of the company's stock after acquiring an additional 163,341 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.45% of Clorox worth $90,088,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brooklyn Investment Group raised its position in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the period. Redwood Park Advisors LLC purchased a new stake in shares of Clorox during the fourth quarter worth about $26,000. Millstone Evans Group LLC bought a new stake in Clorox during the 4th quarter valued at approximately $31,000. Asset Planning Inc purchased a new position in Clorox in the 4th quarter worth approximately $32,000. Finally, GKV Capital Management Co. Inc. bought a new position in Clorox in the 4th quarter worth approximately $32,000. 78.53% of the stock is owned by hedge funds and other institutional investors.
Clorox Trading Down 2.7 %
Shares of NYSE:CLX traded down $3.78 during trading on Thursday, reaching $138.52. 1,812,846 shares of the company were exchanged, compared to its average volume of 1,306,293. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a market capitalization of $17.06 billion, a PE ratio of 37.85, a P/E/G ratio of 2.62 and a beta of 0.61. The business's fifty day simple moving average is $144.83 and its 200-day simple moving average is $155.29. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the firm posted $2.16 earnings per share. On average, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.
Clorox Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.52%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is 133.33%.
Analysts Set New Price Targets
Several research firms have recently commented on CLX. StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. JPMorgan Chase & Co. cut their price objective on Clorox from $173.00 to $151.00 and set a "neutral" rating for the company in a research report on Friday, April 11th. Citigroup decreased their target price on Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research report on Monday, April 14th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Finally, UBS Group decreased their price objective on Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a report on Thursday, April 17th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $153.83.
Check Out Our Latest Stock Report on CLX
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
